H.R. 2617 117th Congress
Consolidated Appropriations Act, 2023
- Became Public Law 117-328
- Economics and Public Finance
- Sponsor: Rep. Connolly, Gerald E. [D-VA-11]
- Congress.gov ↗
Latest action, Dec 29, 2022: Became Public Law No: 117-328.
How the Senate voted: On the Motion
Dec 22, 2022 · Motion Agreed to · 68–29 (it needed 3/5)
- Yea (68)
- Nay (29)
- Didn't vote (3)
- Letters: party (D, R, I)
By party
- Democrat
- Republican
- Independent
Every roll call on it (15)
Each dot is a roll call, in order: how much of the Senate voted yea. The ringed one decided it.
- Carried
- Failed
See the data
| Date | Question | Result | Yea–nay |
|---|---|---|---|
| Dec 22, 2022 | On the Motion | Motion Agreed to | 68–29 |
| Dec 22, 2022 | On the Amendment | Amendment Agreed to | 93–4 |
| Dec 22, 2022 | On the Amendment | Amendment Agreed to | 90–6 |
| Dec 22, 2022 | On the Amendment | Amendment Agreed to | 88–8 |
| Dec 22, 2022 | On the Amendment | Amendment Agreed to | 92–5 |
| Dec 22, 2022 | On the Amendment | Amendment Agreed to | 73–24 |
| Dec 22, 2022 | On the Amendment | Amendment Rejected | 40–57 |
| Dec 22, 2022 | On the Amendment | Amendment Rejected | 44–53 |
| Dec 22, 2022 | On the Amendment | Amendment Rejected | 47–50 |
| Dec 22, 2022 | On the Amendment | Amendment Rejected | 10–87 |
| Dec 22, 2022 | On the Amendment | Amendment Rejected | 47–50 |
| Dec 22, 2022 | On the Amendment | Amendment Rejected | 34–63 |
| Dec 22, 2022 | On the Amendment | Amendment Rejected | 34–63 |
| Dec 22, 2022 | On the Motion | Motion Agreed to | 65–31 |
| Dec 20, 2022 | On the Motion to Proceed | Motion to Proceed Agreed to | 70–25 |
2 cosponsors
Sponsored by Rep. Connolly, Gerald E. [D-VA-11] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
1 D · 1 R
Referred to: Senate: Homeland Security and Governmental Affairs Committee; House: Oversight and Government Reform Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
7 reports
10X GENOMICS
TARPLIN, DOWNS & YOUNG, LLC
1 report
3M COMPANY
1 report
3M COMPANY
MARSHALL & POPP, LLC
1 report
535 GROUP, LLC ON BEHALF OF D-WAVE GOVERNMENT INC.
CAPITOL CHAMBERS STRATEGIES
1 report
A1.9 STRATEGIES LLC O/B/O O'BRIEN, GENTRY, & SCOTT O/B/O AXNES A/S
TIDAL STRATEGIES, LLC
1 report
1 report
AARP, INC.
MEHLMAN CONSULTING, INC.
1 report
ABBOTT (CVC) (FKA CARDIOVASCULAR SYSTEMS, INC, CARDIOVASCULAR COALITION)
LIBERTY PARTNERS GROUP, LLC
1 report
ABBOTT (FORMERLY KNOWN AS ALERE INC.)
TARPLIN, DOWNS & YOUNG, LLC
1 report
ABBOTT FKA CSI (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)
LIBERTY PARTNERS GROUP, LLC
1 report
ABBOTT LABORATORIES
KOUNTOUPES DENHAM CARR & REID, LLC
1 report
ABBVIE
CAPITOL TAX PARTNERS, LLP
1 report
ABBVIE INC.
TARPLIN, DOWNS & YOUNG, LLC
1 report
1 report
All 25 of 1900 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| NATIONAL TREASURY EMPLOYEES UNION | 7 | $1.7M | Q4 2021 | Q3 2022 | yes | |
| 10X GENOMICS | TARPLIN, DOWNS & YOUNG, LLC | 1 | $80K | Q4 2022 | Q4 2022 | yes |
| 3M COMPANY | 1 | $930K | Q4 2022 | Q4 2022 | yes | |
| 3M COMPANY | MARSHALL & POPP, LLC | 1 | $60K | Q4 2022 | Q4 2022 | yes |
| 535 GROUP, LLC ON BEHALF OF D-WAVE GOVERNMENT INC. | CAPITOL CHAMBERS STRATEGIES | 1 | $20K | Q4 2022 | Q4 2022 | yes |
| A1.9 STRATEGIES LLC O/B/O O'BRIEN, GENTRY, & SCOTT O/B/O AXNES A/S | TIDAL STRATEGIES, LLC | 1 | $20K | Q4 2022 | Q4 2022 | yes |
| AARP | 1 | $4.2M | Q4 2022 | Q4 2022 | yes | |
| AARP, INC. | MEHLMAN CONSULTING, INC. | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ABBOTT (CVC) (FKA CARDIOVASCULAR SYSTEMS, INC, CARDIOVASCULAR COALITION) | LIBERTY PARTNERS GROUP, LLC | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ABBOTT (FORMERLY KNOWN AS ALERE INC.) | TARPLIN, DOWNS & YOUNG, LLC | 1 | $80K | Q4 2022 | Q4 2022 | yes |
| ABBOTT FKA CSI (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA) | LIBERTY PARTNERS GROUP, LLC | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ABBOTT LABORATORIES | KOUNTOUPES DENHAM CARR & REID, LLC | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ABBVIE | CAPITOL TAX PARTNERS, LLP | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ABBVIE INC. | TARPLIN, DOWNS & YOUNG, LLC | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ABBVIE INC. | 1 | $970K | Q4 2022 | Q4 2022 | yes | |
| ABBVIE INC. | OGR | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ACADEMY OF MANAGED CARE PHARMACY | 1 | $90K | Q4 2022 | Q4 2022 | yes | |
| ACADEMY OF MODEL AERONAUTICS | CAPITOL HILL POLICY GROUP LLC | 1 | $50K | Q4 2022 | Q4 2022 | yes |
| ACADIA PHARMACEUTICALS | 1 | $370K | Q4 2022 | Q4 2022 | yes | |
| ACADIAN COMPANIES | OGR | 1 | $20K | Q4 2022 | Q4 2022 | yes |
| ACCENTCARE, INC. | THE NICKLES GROUP, LLC | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ACCENTURE FEDERAL SERVICES | TARPLIN, DOWNS & YOUNG, LLC | 1 | $0 | Q4 2022 | Q4 2022 | yes |
| ACCENTURE LLP | 1 | $630K | Q4 2022 | Q4 2022 | yes | |
| ACT FOR NIH | NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC) | 1 | $20K | Q4 2022 | Q4 2022 | yes |
| ACTION NOW INITIATIVE, LLC (ANI) | CROSSROADS STRATEGIES, LLC | 1 | $50K | Q4 2022 | Q4 2022 | yes |